Share
 
Title
Code
Session Type
CME accreditation
ROOM/CHANNEL
Date Time
Moderator

The Journal of the International AIDS Society (JIAS) has increasingly prioritized and published papers utilizing the scientific approaches of implementation science, given the advent of effective, evidence-based interventions for HIV treatment and prevention. However, many researchers, community leaders and policy makers are not always clear on what constitutes implementation science and how funders and implementers determine priorities, study designs and analyses.
Please join JIAS Editors in learning from colleagues at the NIH, the Bill & Melinda Gates Foundation, the ANRS and PEPFAR as they discuss their view of the current state of implementation science, as well as near-term and long-term opportunities to contribute to this burgeoning area of research. The panellists will review their organizations' priorities and provide examples of how implementation science has helped to drive policy and vice versa. They will discuss where they feel the field is headed.

11:45
3 min
Welcome and introductions
Kenneth MAYER, Fenway Health, United States
11:48
5 min
The future of HIV implementation science
Kenneth MAYER, Fenway Health, United States
11:53
25 min
Moderated discussion: How does implementation science affect HIV policy and vice versa?
Kenneth MAYER, Fenway Health, United States
Dianne RAUSCH, NIMH, United States
Yazdan YAZDANPANAH, ANRS, France
Geoffrey GARNETT, The Bill & Melinda Gates Foundation, United States
Angeli ACHREKAR, PEPFAR, United States
12:18
5 min
JIAS impact awards
Annette SOHN, amfAR, the Foundation for AIDS Research, Thailand
12:23
2 min
Introducing the Field notes: a new JIAS feature
Marlene BRAS, IAS, Switzerland
12:25
5 min
A JIAS Field note – 'Certification of lay providers to deliver key population-led HIV services in Thailand’s national healthcare system: Lessons learned'
Nittaya PHANUPHAK, Institute of HIV Research and Innovation, Thailand
12:30
5 min
Implementation science in action: Perspective from Kenya
Emmah OWIDI, Partners in Health and Research Development, Kenya
12:35
10 min
Q&A with discussants and presenters
Kenneth MAYER, Fenway Health, United States
Emmah OWIDI, Partners in Health and Research Development, Kenya
Dianne RAUSCH, NIMH, United States
Nittaya PHANUPHAK, Institute of HIV Research and Innovation, Thailand
Yazdan YAZDANPANAH, ANRS, France
Geoffrey GARNETT, The Bill & Melinda Gates Foundation, United States
Angeli ACHREKAR, PEPFAR, United States
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT